SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-22-009104
Filing Date
2022-05-17
Accepted
2022-05-17 16:08:47
Documents
5
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20220517x6k.htm 6-K 19551
2 EX-99.1 tmb-20220517xex99d1.htm EX-99.1 663047
3 EX-99.2 tmb-20220517xex99d2.htm EX-99.2 137013
4 EX-99.3 tmb-20220517xex99d3.htm EX-99.3 163468
5 GRAPHIC tmb-20220517xex99d3001.jpg GRAPHIC 3162
  Complete submission text file 0001558370-22-009104.txt   988652
Mailing Address YALELAAN 60 UTRECHT P7 3584 CM
Business Address YALELAAN 60 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40241 | Film No.: 22934518
SIC: 2834 Pharmaceutical Preparations